IONIS-FGFR4Rx

DB16198InvestigationalGene Therapies

IONIS-FGFR4Rx is under investigation in clinical trial NCT02476019 (A Safety, Tolerability, PK, and PD Study of Once Weekly ISIS-FGFR4RX SC in Obese Patients).

Mechanism: Pharmacologically active on Fibroblast growth factor receptor 4
Curator reviewed
Also known as: Isis-fgfr4rx
Code names: ISIS-463588

Resolves to

Compound

UNIIYJ4APB5MQCCAS1416376-17-4

Targets

P22455FGFR4

What you can answer from here — as of July 08, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with IONIS-FGFR4Rx, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account